Slides
“Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”
Thomas Nedelec
Paris Brain Institute
“Dissecting the causal question underlying the association between cancer and dementia”
L. Paloma Rojas-Saunero
Erasmus MC
“Using State Space Models for Longitudinal Neuropsychological Outcomes”
Zach Baucom
Boston University School of Public Health
“Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development”
Lon Schneider
University of Southern California
“The Challenge of Health Equity in Clinical Research: Towards a Quantifiable Science of Inclusion.”
Jonathan Jackson
Harvard Medical School/Massachusetts General Hospital
The Challenge of Health Equity in Clinical Research_ JJackson_2020
“Towards Real-World Data for Dementia Studies: Use of machine-learning to improve metrics”
Deborah Blacker & Sudha Seshadri
Harvard Medical School/Massachusetts General Hospital
Towards Real-World Data for Dementia Studies_SDas_DBlacker_2020
“Implications of covid for dementia researchers”
Bryan James
Rush Alzheimer’s Disease Center
The intersection of COVID-19 and dementia: a double hit for older adults_BJames_2020